Ken Dixon, MD, FACS

Proud to be recognized as a finalist in the 50 on Fire awards for providing new options and more hope for cancer patients everywhere.

I hope you will join Dr. Barrott and I as we discuss the patient's important role in his/her cancer journey.

Join us this Thursday at 4:30pm ET for the final installment of our series, Treating Cancer in a COVID-19 World. Feel free to post any questions you would like us to cover below.

I hope you enjoy this conversation we had with Dr. Tony Letai of Dana Farber/Harvard and The Society of Functional Precision Medicine.

I hope you can join us this Thursday. Please share this event so that we may share how we provide hope and options to as many cancer patients as possible.

I appreciate the opportunity to share my thoughts on how COVID-19 has mandated a new normal going forward.

I hope you will join us this Thursday, April 30th at 4:30pm EST as we discuss the importance of cancer patients owning their own tumor tissue.

I hope you can join us today for our live event to discuss the importance of the cancer patient owning their tumor tissue. I look forward to this discussion.

Join us today at 4:30pm EST to learn why every cancer patient should own their tumor tissue. I look forward to the discussion with you online.

SpeciCare remains focused during these trying times to help cancer patients find the best treatment possible for their individual situation.

Working hard for our patients...

We are excited to share our collaboration with Lena Biosciences. Working together to advance precision options for all cancer patients, SpeciCare and Lena Biosciences are on the forefront of this emerging industry and focused on helping the patient control his/her tissue and care to generate the best possible outcome.